gvtcx

supplier · GB-PPONPNYV-5437-GRVP

Hikma Pharmaceuticals

London W1S2HR combined from 2 published records

Hikma Pharmaceuticals has won 15 UK public sector awards from 6 buyers since 2025. The typical award is worth £11,330,726.

as a supplier

15 recorded awards from 6 buyers , between 10 Nov 2025 and 26 Aug 2026.

awards won
15
exclusive
0%
0 sole-winner awards
median award
£11.3m
largest
£16.8m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Hikma Pharmaceuticals

How many public sector contracts has Hikma Pharmaceuticals won?

Hikma Pharmaceuticals has won 15 UK public sector contracts from 6 public bodies since 2025.

Which public bodies buy from Hikma Pharmaceuticals?

Hikma Pharmaceuticals has won the most contracts from NHS England, Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts and NHS England.

How large are Hikma Pharmaceuticals's contracts?

The median published value of a contract won by Hikma Pharmaceuticals is £11,330,726. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Hikma Pharmaceuticals contracts are expiring soon?

1 contract involving Hikma Pharmaceuticals has an end date in the next 12 months, the earliest on 31 May 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contract counterparty value ends
NHS National Generic Pharmaceuticals Wave 15a NHS England · 31 May 2027

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £21,026,178 26 Aug 2026
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 3 Jun 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
Generic Drugs – Injections/Infusions 2 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £5,857,450 3 Mar 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · 6 Jan 2026
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
Aseptics Medicines (Including Cytotoxics) shared Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts) · 31 Jul 2025
NP30925 Psychiatry and Neurology Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 23 Apr 2025
NHS National Generic Pharmaceuticals Wave 15a shared NHS England · 4 Jul 2024
Generic Anti-Infective Drugs shared Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) · 19 Mar 2024
Generic Drugs - Injections/Infusions shared Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts · 3 Aug 2022

every contract won by Hikma Pharmaceuticals →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Hikma Pharmaceuticals GB-PPON PNYV-5437-GRVP W1S 2HR 8
Hikma Pharmaceuticals · W1S 2HR 7

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 2 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.